(NYSE: SCL) Stepan Co's forecast annual revenue growth rate of 8.57% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.26%.
Stepan Co's revenue in 2025 is $2,222,111,000.On average, 1 Wall Street analysts forecast SCL's revenue for 2025 to be $52,815,507,901, with the lowest SCL revenue forecast at $52,815,507,901, and the highest SCL revenue forecast at $52,815,507,901.
In 2026, SCL is forecast to generate $56,586,108,884 in revenue, with the lowest revenue forecast at $56,586,108,884 and the highest revenue forecast at $56,586,108,884.